Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. fibrosis tissue
Show results for
Products
Applications

Companies

News
Articles

Refine by
Date

  • Older

Fibrosis Tissue Articles & Analysis

8 news found

Gesynta Pharma prepares Phase II study of GS-248 in endometriosis following ground-breaking data from a preclinical proof-of-concept study

Gesynta Pharma prepares Phase II study of GS-248 in endometriosis following ground-breaking data from a preclinical proof-of-concept study

Endometriosis is an estrogen-driven, chronic inflammatory disease characterized by the presence of tissue resembling endometrium (the lining of the uterus) outside the uterus. It causes a chronic inflammatory reaction that may result in the formation of scar tissue (adhesions and fibrosis) within the pelvis and other parts of the body. ...

ByGesynta Pharma AB


AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma

AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma

We believe MINIject®’s distinctive tissue-integrating capabilities unlock a safer, and more effective option for patients. ...

ByiSTAR Medical SA


iSTAR Medical Presents Positive Consistent Results for MINIject Across Three International Glaucoma Trials

iSTAR Medical Presents Positive Consistent Results for MINIject Across Three International Glaucoma Trials

We believe MINIject®’s distinctive tissue-integrating capabilities unlock a safer, and more effective option for patients. ...

ByiSTAR Medical SA


iSTAR Medical Expands Commercial Rollout with First MINIject Surgeries in Switzerland

iSTAR Medical Expands Commercial Rollout with First MINIject Surgeries in Switzerland

We believe MINIject®’s distinctive tissue-integrating capabilities unlock a safer, and more effective option for patients. ...

ByiSTAR Medical SA


iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject

iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject

Vold, from Vold Vision in Fayetteville, AR (USA), a long-standing contributor to ophthalmic device development and STAR-V trial investigator commented: “There is significant untapped potential in targeting the supraciliary space when leveraging MIGS to treat glaucoma, and MINIject enables this to be captured. iSTAR Medical’s approach uses its unique silicone micropore ...

ByiSTAR Medical SA


BenevolentAI Achieves Second Major Collaboration Milestone With Novel Idiopathic Pulmonary Fibrosis Target Selected For AstraZeneca’s Portfolio

BenevolentAI Achieves Second Major Collaboration Milestone With Novel Idiopathic Pulmonary Fibrosis Target Selected For AstraZeneca’s Portfolio

Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI’s AI-drug discovery platform and experimentally validated by AstraZeneca Announcement represents the second collaboration milestone following the addition of a novel chronic kidney disease target to AstraZeneca’s portfolio in Q1 2021 London, 15 December 2021: BenevolentAI, a ...

ByBenevolent


LISCure Biosciences received clinical approval for two microbiome programs targeting autoimmune disease and NASH

LISCure Biosciences received clinical approval for two microbiome programs targeting autoimmune disease and NASH

LB-P8 has entered the final stage of the study on its mechanism of action, and through additional mechanism studies, anti-fibrosis and tissue necrosis inhibitory effects have been confirmed in rare hepatic biliary diseases. ...

ByLISCure Biosciences Inc.


TIKOMED’S ILB® resolves inflammatory scarring and promotes functional tissue repair in data published in npj Regenerative Medicine

TIKOMED’S ILB® resolves inflammatory scarring and promotes functional tissue repair in data published in npj Regenerative Medicine

The peer-reviewed data from rodent and human disease models showed that ILB® leads to tissue remodelling, reduced fibrosis and functional tissue regeneration – observations indicating the potential of ILB® to alleviate fibrotic diseases. ...

ByTIKOMED AB

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT